Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
FUU
FUU
Name:2-(3-((3-(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)ureido)methyl)phenoxy)acetic acid
Formula:C16 H14 N4 O6
SMILES:O=C(Nc1nnc(o1)c2occc2)NCc3cccc(OCC(=O)O)c3
InChi:InChI=1S/C16H14N4O6/c21-13(22)9-25-11-4-1-3-10(7-11)8-17-15(23)18-16-20-19-14(26-16)12-5-2-6-24-12/h1-7H,8-9H2,(H,21,22)(H2,17,18,20,23)
Definition date:2012-01-26
Last modified:2013-01-11
Release date:2013-01-11
Identifier:{3-[({[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]carbamoyl}amino)methyl]phenoxy}acetic acid
T39
T39
Name:2'-O-METHOXYETHYLENE THYMIDINE 5'-MONOPHOSPHATE
Formula:C13 H21 N2 O10 P
SMILES:O=P(O)(O)OCC2OC(N1C(=O)NC(=O)C(=C1)C)C(OCCOC)C2O
InChi:InChI=1S/C13H21N2O10P/c1-7-5-15(13(18)14-11(7)17)12-10(23-4-3-22-2)9(16)8(25-12)6-24-26(19,20)21/h5,8-10,12,16H,3-4,6H2,1-2H3,(H,14,17,18)(H2,19,20,21)/t8-,9-,10-,12-/m1/s1
Definition date:1998-07-29
Last modified:2013-01-10
Identifier:2'-O-(2-methoxyethyl)-5-methyluridine 5'-(dihydrogen phosphate)
A44
A44
Name:2'-O-METHYOXYETHYL-ADENOSINE 5'-MONOPHOSPHATE
Formula:C13 H20 N5 O8 P
SMILES:O=P(O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(OCCOC)C3O
InChi:InChI=1S/C13H20N5O8P/c1-23-2-3-24-10-9(19)7(4-25-27(20,21)22)26-13(10)18-6-17-8-11(14)15-5-16-12(8)18/h5-7,9-10,13,19H,2-4H2,1H3,(H2,14,15,16)(H2,20,21,22)/t7-,9-,10-,13-/m1/s1
Definition date:1999-05-12
Last modified:2013-01-10
Identifier:2'-O-(2-methoxyethyl)adenosine 5'-(dihydrogen phosphate)
G48
G48
Name:2'-O-METHYOXYETHYL-GUANOSINE-5'-MONOPHOSPHATE
Formula:C13 H20 N5 O9 P
SMILES:O=P(O)(O)OCC3OC(n2cnc1c2N=C(N)NC1=O)C(OCCOC)C3O
InChi:InChI=1S/C13H20N5O9P/c1-24-2-3-25-9-8(19)6(4-26-28(21,22)23)27-12(9)18-5-15-7-10(18)16-13(14)17-11(7)20/h5-6,8-9,12,19H,2-4H2,1H3,(H2,21,22,23)(H3,14,16,17,20)/t6-,8-,9-,12-/m1/s1
Definition date:1999-05-12
Last modified:2013-01-10
Identifier:2'-O-(2-methoxyethyl)guanosine 5'-(dihydrogen phosphate)
LP4
LP4
Name:2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-4-O-phosphono-beta-D-glucopyranose
Formula:C34 H66 N O12 P
SMILES:O=P(O)(O)OC1C(OC(O)C(NC(=O)CC(O)CCCCCCCCCCC)C1OC(=O)CC(O)CCCCCCCCCCC)CO
InChi:InChI=1S/C34H66NO12P/c1-3-5-7-9-11-13-15-17-19-21-26(37)23-29(39)35-31-33(32(47-48(42,43)44)28(25-36)45-34(31)41)46-30(40)24-27(38)22-20-18-16-14-12-10-8-6-4-2/h26-28,31-34,36-38,41H,3-25H2,1-2H3,(H,35,39)(H2,42,43,44)/t26-,27-,28-,31-,32-,33-,34-/m1/s1
Definition date:2006-12-26
Last modified:2013-01-08
Identifier:2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-4-O-phosphono-beta-D-glucopyranose
NTR
NTR
Name:META-HYDROXY BETA NOR-TYROSINE
Formula:C8 H9 N O4
SMILES:O=C(O)C(c1cc(O)c(O)cc1)N
InChi:InChI=1S/C8H9NO4/c9-7(8(12)13)4-1-2-5(10)6(11)3-4/h1-3,7,10-11H,9H2,(H,12,13)/t7-/m1/s1
Definition date:2002-09-02
Last modified:2013-01-04
Release date:2013-01-04
Identifier:(2R)-amino(3,4-dihydroxyphenyl)ethanoic acid
10E
10E
Name:(2E)-4-amino-3-methylbut-2-en-1-yl trihydrogen diphosphate
Formula:C5 H13 N O7 P2
SMILES:O=P(O)(O)OP(=O)(OCC=C(/C)CN)O
InChi:InChI=1S/C5H13NO7P2/c1-5(4-6)2-3-12-15(10,11)13-14(7,8)9/h2H,3-4,6H2,1H3,(H,10,11)(H2,7,8,9)/b5-2+
Definition date:2012-09-19
Last modified:2013-01-04
Release date:2013-01-04
Identifier:(2E)-4-amino-3-methylbut-2-en-1-yl trihydrogen diphosphate
10G
10G
Name:(2E)-3-methyl-4-sulfanylbut-2-en-1-yl trihydrogen diphosphate
Formula:C5 H12 O7 P2 S
SMILES:O=P(OP(=O)(OC/C=C(C)CS)O)(O)O
InChi:InChI=1S/C5H12O7P2S/c1-5(4-15)2-3-11-14(9,10)12-13(6,7)8/h2,15H,3-4H2,1H3,(H,9,10)(H2,6,7,8)/b5-2+
Definition date:2012-09-19
Last modified:2013-01-04
Release date:2013-01-04
Identifier:(2E)-3-methyl-4-sulfanylbut-2-en-1-yl trihydrogen diphosphate
17V
17V
Name:2-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide
Formula:C18 H18 N4 O2 S
SMILES:O=C(N)c3cc4OCCc2c(sc(c1ncnn1C(C)C)c2)c4cc3
InChi:InChI=1S/C18H18N4O2S/c1-10(2)22-18(20-9-21-22)15-8-11-5-6-24-14-7-12(17(19)23)3-4-13(14)16(11)25-15/h3-4,7-10H,5-6H2,1-2H3,(H2,19,23)
Definition date:2012-10-29
Last modified:2013-01-04
Release date:2013-01-04
Identifier:2-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide
LBF
LBF
Name:Leptomycin B
Formula:C33 H48 O6
SMILES:O=C(O)C=C(/C)CC(C)C(O)C(C(=O)C(/C=C(/C=C/CC(/C=C(C=CC1OC(=O)C=CC1C)CC)C)C)C)C
InChi:InChI=1S/C33H48O6/c1-9-28(14-15-29-24(5)13-16-31(36)39-29)19-22(3)12-10-11-21(2)17-25(6)32(37)27(8)33(38)26(7)18-23(4)20-30(34)35/h10-11,13-17,19-20,22,24-27,29,33,38H,9,12,18H2,1-8H3,(H,34,35)/b11-10+,15-14+,21-17+,23-20+,28-19-/t22-,24+,25-,26+,27-,29+,33-/m1/s1
Definition date:2012-10-11
Last modified:2013-01-04
Release date:2013-01-04
Identifier:(2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-19-[(2S,3S)-3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl]-8-oxononadeca-2,10,12,16,18-pentaenoic acid
19G
19G
Name:3-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-1-benzothiophene-2-carboxylic acid
Formula:C20 H19 Cl O3 S
SMILES:Clc3c(cc(OCCCc1c2ccccc2sc1C(=O)O)cc3C)C
InChi:InChI=1S/C20H19ClO3S/c1-12-10-14(11-13(2)18(12)21)24-9-5-7-16-15-6-3-4-8-17(15)25-19(16)20(22)23/h3-4,6,8,10-11H,5,7,9H2,1-2H3,(H,22,23)
Definition date:2012-11-08
Last modified:2013-01-04
Release date:2013-01-04
Identifier:3-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-1-benzothiophene-2-carboxylic acid
19H
19H
Name:6-chloro-3-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-1H-indole-2-carboxylic acid
Formula:C20 H19 Cl2 N O3
SMILES:Clc3c(cc(OCCCc2c1ccc(Cl)cc1nc2C(=O)O)cc3C)C
InChi:InChI=1S/C20H19Cl2NO3/c1-11-8-14(9-12(2)18(11)22)26-7-3-4-16-15-6-5-13(21)10-17(15)23-19(16)20(24)25/h5-6,8-10,23H,3-4,7H2,1-2H3,(H,24,25)
Definition date:2012-11-08
Last modified:2013-01-04
Release date:2013-01-04
Identifier:6-chloro-3-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-1H-indole-2-carboxylic acid
1C4
1C4
Name:(2S)-2-({(3S,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14,20-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaicosan-20-yl}amino)pentanedioic acid (non-preferred name)
Formula:C28 H45 N8 O21 P3 S
SMILES:O=C(O)C(NC(=O)CSCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3OP(=O)(O)O)CCC(=O)O
InChi:InChI=1S/C28H45N8O21P3S/c1-28(2,22(42)25(43)31-6-5-16(37)30-7-8-61-10-17(38)35-14(27(44)45)3-4-18(39)40)11-54-60(51,52)57-59(49,50)53-9-15-21(56-58(46,47)48)20(41)26(55-15)36-13-34-19-23(29)32-12-33-24(19)36/h12-15,20-22,26,41-42H,3-11H2,1-2H3,(H,30,37)(H,31,43)(H,35,38)(H,39,40)(H,44,45)(H,49,50)(H,51,52)(H2,29,32,33)(H2,46,47,48)/t14-,15+,20+,21+,22-,26+/m0/s1
Definition date:2012-11-30
Last modified:2013-01-04
Release date:2013-01-04
Identifier:(2S)-2-({(3S,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14,20-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaicosan-20-yl}amino)pentanedioic acid (non-preferred name)
LMB
LMB
Name:Leptomycin B, bound form
Formula:C33 H52 O7
SMILES:O=C(O)CCC(C)C(O)/C=C/C(=CC(C)C/C=C/C(=C/C(C(=O)C(C)C(O)C(C)CC(=CC(=O)O)C)C)C)CC
InChi:InChI=1S/C33H52O7/c1-9-28(14-15-29(34)24(5)13-16-30(35)36)19-22(3)12-10-11-21(2)17-25(6)32(39)27(8)33(40)26(7)18-23(4)20-31(37)38/h10-11,14-15,17,19-20,22,24-27,29,33-34,40H,9,12-13,16,18H2,1-8H3,(H,35,36)(H,37,38)/b11-10+,15-14+,21-17+,23-20+,28-19-/t22-,24+,25-,26+,27-,29+,33-/m1/s1
Definition date:2012-10-11
Last modified:2013-01-04
Release date:2013-01-04
Identifier:(2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E,20R,21S)-17-ethyl-6,20-dihydroxy-3,5,7,9,11,15,21-heptamethyl-8-oxotetracosa-2,10,12,16,18-pentaenedioic acid
A2Y
A2Y
Name:(3S,5S,7S)-N-{[5-(thiophen-2-yl)-1,2-oxazol-3-yl]methyl}tricyclo[3.3.1.1~3,7~]decan-1-aminium
Formula:C18 H23 N2 O S
SMILES:n2oc(c1sccc1)cc2C[NH2+]C45CC3CC(CC(C3)C4)C5
InChi:InChI=1S/C18H22N2OS/c1-2-17(22-3-1)16-7-15(20-21-16)11-19-18-8-12-4-13(9-18)6-14(5-12)10-18/h1-3,7,12-14,19H,4-6,8-11H2/p+1/t12-,13+,14-,18-
Definition date:2012-09-11
Last modified:2013-01-04
Release date:2013-01-04
Identifier:(3S,5S,7S)-N-{[5-(thiophen-2-yl)-1,2-oxazol-3-yl]methyl}tricyclo[3.3.1.1~3,7~]decan-1-aminium
AA8
AA8
Name:Anguinomycin A, bound form
Formula:C31 H48 O7
SMILES:O=C(O)CCCC(O)/C=C/C(=CC(C)C/C=C/C(=C/C(C(=O)C(C)C(O)C(C)CC(=CC(=O)O)C)C)C)C
InChi:InChI=1S/C31H48O7/c1-20(16-22(3)14-15-27(32)12-9-13-28(33)34)10-8-11-21(2)17-24(5)30(37)26(7)31(38)25(6)18-23(4)19-29(35)36/h8,11,14-17,19-20,24-27,31-32,38H,9-10,12-13,18H2,1-7H3,(H,33,34)(H,35,36)/b11-8+,15-14+,21-17+,22-16-,23-19+/t20-,24-,25+,26-,27-,31-/m1/s1
Definition date:2012-10-11
Last modified:2013-01-04
Release date:2013-01-04
Identifier:(2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E,20R)-6,20-dihydroxy-3,5,7,9,11,15,17-heptamethyl-8-oxotetracosa-2,10,12,16,18-pentaenedioic acid
DG8
DG8
Name:2'-deoxy-8-(pyren-1-ylamino)guanosine 5'-(dihydrogen phosphate)
Formula:C26 H23 N6 O7 P
SMILES:O=P(O)(O)OCC7OC(n2c(nc1c2N=C(N)NC1=O)Nc6c3c5c4c(cc3)cccc4ccc5cc6)CC7O
InChi:InChI=1S/C26H23N6O7P/c27-25-30-23-22(24(34)31-25)29-26(32(23)19-10-17(33)18(39-19)11-38-40(35,36)37)28-16-9-7-14-5-4-12-2-1-3-13-6-8-15(16)21(14)20(12)13/h1-9,17-19,33H,10-11H2,(H,28,29)(H2,35,36,37)(H3,27,30,31,34)/t17-,18+,19+/m0/s1
Definition date:2012-05-15
Last modified:2013-01-04
Release date:2013-01-04
Identifier:2'-deoxy-8-(pyren-1-ylamino)guanosine 5'-(dihydrogen phosphate)
M61
M61
Name:N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N'-{5-oxo-3-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl}sulfuric diamide
Formula:C28 H32 N6 O5 S
SMILES:O=C4c1cc(ccc1C=Cc5ncc(c2cn(nc2)C3CCNCC3)cc45)NS(=O)(=O)N(CC6OCCOC6)C
InChi:InChI=1S/C28H32N6O5S/c1-33(17-24-18-38-10-11-39-24)40(36,37)32-22-4-2-19-3-5-27-26(28(35)25(19)13-22)12-20(14-30-27)21-15-31-34(16-21)23-6-8-29-9-7-23/h2-5,12-16,23-24,29,32H,6-11,17-18H2,1H3/t24-/m1/s1
Definition date:2011-03-23
Last modified:2013-01-03
Identifier:N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N'-{5-oxo-3-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl}sulfuric diamide
0D2
0D2
Name:(4R,4'S)-4,4'-diphenyl-4,4'-biimidazolidine-2,2',5,5'-tetrone
Formula:C18 H14 N4 O4
SMILES:O=C2NC(=O)NC2(c1ccccc1)C3(C(=O)NC(=O)N3)c4ccccc4
InChi:InChI=1S/C18H14N4O4/c23-13-17(21-15(25)19-13,11-7-3-1-4-8-11)18(12-9-5-2-6-10-12)14(24)20-16(26)22-18/h1-10H,(H2,19,21,23,25)(H2,20,22,24,26)/t17-,18+
Definition date:2011-12-13
Last modified:2012-12-28
Release date:2012-12-28
Identifier:(4R,4'S)-4,4'-diphenyl-4,4'-biimidazolidine-2,2',5,5'-tetrone
1BV
1BV
Name:(2R,6S,7E,10E,13aR,14aR,16aS)-2-{[7-methoxy-8-methyl-2-(propan-2-yloxy)quinolin-4-yl]oxy}-N-[(1-methylcyclopropyl)sulfonyl]-6-{[(1-methyl-1H-pyrazol-3-yl)carbonyl]amino}-5,16-dioxo-1,2,3,6,9,12,13,13a,14,15,16,16a-dodecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide
Formula:C41 H51 N7 O9 S
SMILES:O=C(NC2C=CCC=CCCC6CC6(C(=O)NS(=O)(=O)C1(C)CC1)NC(=O)C5N(C2=O)CC(Oc3c4ccc(OC)c(c4nc(OC(C)C)c3)C)C5)c7nn(cc7)C
InChi:InChI=1S/C41H51N7O9S/c1-24(2)56-34-21-33(28-14-15-32(55-6)25(3)35(28)43-34)57-27-20-31-37(50)44-41(39(52)46-58(53,54)40(4)17-18-40)22-26(41)12-10-8-7-9-11-13-30(38(51)48(31)23-27)42-36(49)29-16-19-47(5)45-29/h7-8,11,13-16,19,21,24,26-27,30-31H,9-10,12,17-18,20,22-23H2,1-6H3,(H,42,49)(H,44,50)(H,46,52)/b8-7+,13-11+/t26-,27-,30+,31+,41-/m1/s1
Definition date:2012-11-28
Last modified:2012-12-28
Release date:2012-12-28
Identifier:(2R,6S,7E,10E,13aR,14aR,16aS)-2-{[7-methoxy-8-methyl-2-(propan-2-yloxy)quinolin-4-yl]oxy}-N-[(1-methylcyclopropyl)sulfonyl]-6-{[(1-methyl-1H-pyrazol-3-yl)carbonyl]amino}-5,16-dioxo-1,2,3,6,9,12,13,13a,14,15,16,16a-dodecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide
6C6
6C6
Name:N-cyclopentyladenosine 5'-(dihydrogen phosphate)
Formula:C15 H22 N5 O7 P
SMILES:O=P(O)(O)OCC4OC(n2cnc1c(ncnc12)NC3CCCC3)C(O)C4O
InChi:InChI=1S/C15H22N5O7P/c21-11-9(5-26-28(23,24)25)27-15(12(11)22)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,21-22H,1-5H2,(H,16,17,19)(H2,23,24,25)/t9-,11-,12-,15-/m1/s1
Definition date:2012-07-13
Last modified:2012-12-28
Release date:2012-12-28
Identifier:N-cyclopentyladenosine 5'-(dihydrogen phosphate)
BLK
BLK
Name:[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] (2S)-2-azanyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoate
Formula:C21 H34 N7 O10 P
SMILES:O=C(OC(C)(C)C)NCCCCC(N)C(=O)OP(=O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3O
InChi:InChI=1S/C21H34N7O10P/c1-21(2,3)37-20(32)24-7-5-4-6-11(22)19(31)38-39(33,34)35-8-12-14(29)15(30)18(36-12)28-10-27-13-16(23)25-9-26-17(13)28/h9-12,14-15,18,29-30H,4-8,22H2,1-3H3,(H,24,32)(H,33,34)(H2,23,25,26)/t11-,12+,14+,15+,18+/m0/s1
Definition date:2012-05-01
Last modified:2012-12-28
Release date:2012-12-28
Identifier:5'-O-[(R)-({(2S)-2-amino-6-[(tert-butoxycarbonyl)amino]hexanoyl}oxy)(hydroxy)phosphoryl]adenosine
TIA
TIA
Name:2-(1,5-DIDEOXYRIBOSE)-4-AMIDO-THIAZOLE
Formula:C9 H12 N2 O4 S
SMILES:O=C(c1nc(sc1)C2OC(C(O)C2O)C)N
InChi:InChI=1S/C9H12N2O4S/c1-3-5(12)6(13)7(15-3)9-11-4(2-16-9)8(10)14/h2-3,5-7,12-13H,1H3,(H2,10,14)/t3-,5-,6-,7-/m1/s1
Definition date:1999-07-08
Last modified:2012-12-21
Identifier:(1R)-1,4-anhydro-1-(4-carbamoyl-1,3-thiazol-2-yl)-5-deoxy-D-ribitol
RS8
RS8
Name:N-[(2-amino-4-oxo-1,4-dihydropteridin-7-yl)carbonyl]glycyl-L-phenylalanine
Formula:C18 H17 N7 O5
SMILES:O=C(O)C(NC(=O)CNC(=O)c1nc2c(nc1)C(=O)N=C(N)N2)Cc3ccccc3
InChi:InChI=1S/C18H17N7O5/c19-18-24-14-13(16(28)25-18)20-7-11(23-14)15(27)21-8-12(26)22-10(17(29)30)6-9-4-2-1-3-5-9/h1-5,7,10H,6,8H2,(H,21,27)(H,22,26)(H,29,30)(H3,19,23,24,25,28)/t10-/m0/s1
Definition date:2012-11-09
Last modified:2012-12-21
Release date:2012-12-21
Identifier:N-[(2-amino-4-oxo-1,4-dihydropteridin-7-yl)carbonyl]glycyl-L-phenylalanine
11H
11H
Name:9,10-dioxo-9,10-dihydroanthracene-2,6-disulfonic acid
Formula:C14 H8 O8 S2
SMILES:O=S(=O)(O)c3ccc2C(=O)c1c(ccc(c1)S(=O)(=O)O)C(=O)c2c3
InChi:InChI=1S/C14H8O8S2/c15-13-9-3-1-7(23(17,18)19)5-11(9)14(16)10-4-2-8(6-12(10)13)24(20,21)22/h1-6H,(H,17,18,19)(H,20,21,22)
Definition date:2012-09-28
Last modified:2012-12-21
Release date:2012-12-21
Identifier:9,10-dioxo-9,10-dihydroanthracene-2,6-disulfonic acid

223532

PDB entries from 2024-08-07

PDB statisticsPDBj update infoContact PDBjnumon